Skip to main content
Premium Trial:

Request an Annual Quote

Millennium to Share Bioinformatics Resources with New Subsidiary

Premium

CAMBRIDGE, Mass.--Millennium Pharmaceuticals Inc. has announced that it will make its bioinformatics services, along with other critical research, technology, and automation functions, available to its newly announced subsidiary, Millennium BioTherapeutics Inc. The new company is charged with developing and commercializing therapeutic proteins, antibody therapy, gene therapy, and antisense products. Eli Lilly & Co. is an 18 percent shareholder in exchange for a $20 million investment, and has entered into a multiyear collaborative with Millennium BioThera peutics for the discovery, development, and commercialization of novel therapeutic protein products.

In conjunction with the launch, Millennium Pharmaceuticals has transferred to Millennium BioTherapeutics certain product development rights.

"Access to Millennium's genetics, computational and bench biology, and diverse disease-research expertise provides Millennium BioTherapeutics with a distinct competitive advantage," commented John Maraganore, vice-president and general manager of the new company. He was previously in management at Biogen.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.